Cite

HARVARD Citation

    Rimsky, L. et al. (2013). 96-Week Resistance Analyses of Rilpivirine in Treatment-Naive, HIV-1-Infected Adults from the Echo and Thrive Phase Iii Trials. Antiviral therapy. 18 (8), pp. 967-977. [Online]. 
  
Back to record